LOGROS Y ACTUALIZACIONES DESTACADAS
VYF04 – Enrollment Goal Compliance
On April 10, 2026, Research Without Limits successfully completed the enrollment of the 200 participants initially assigned for the VYF04 study. As a result of the site's excellent performance, the sponsor SANOFI assigned 150 additional participants for Honduras, initiating a new enrollment phase on May 10, 2026.
PSK00029 – Sustained Progress in Enrollment
The PSK00029 study continues to progress satisfactorily, reaching a total of 200 enrolled participants. This result reflects the team's commitment to meeting the established goals and the weekly quotas agreed upon with the sponsor.
VBT00004 – Selection for New Study
Research Without Limits was selected to participate in the VBT00004 study, a clinical trial aimed at adults over 60 years old that will evaluate a combined vaccine against influenza and COVID-19. This selection reaffirms the confidence of sponsors and CROs in the operational and scientific capacity of the center.
International Participation – Researchland 2026
Representatives of Research Without Limits participated in Researchland 2026: "Innovation Without Limits," held in Mexico City on May 19, 20, and 21, 2026. This event, considered the most important annual clinical research congress in Mexico, brought together researchers, academics, and industry professionals to exchange knowledge and discuss the trends that will define the future of clinical research in the region.